**Question:** Troponin-T is preferable to CPK-MB in the diagnosis of acute myocardial Infarction (MI) in all of the following situations except-

A. Acute coronary syndromes with normal cardiac enzymes
B. Acute myocardial infarction with elevated CPK-MB
C. Acute myocardial infarction with low cardiac enzyme release
D. Acute myocardial infarction with significant renal dysfunction

**Correct Answer:** **A. Acute coronary syndromes with normal cardiac enzymes**

**Core Concept:** Troponin-T and CPK-MB are cardiac biomarkers used to diagnose acute myocardial infarction (MI). Troponin-T is a highly specific and sensitive marker for cardiac damage, while CPK-MB is a less specific marker with a broader range of applications.

**Why the Correct Answer is Right:** In the case of acute coronary syndromes with normal cardiac enzymes, the release of cardiac biomarkers is not significantly elevated, making Troponin-T and CPK-MB less useful for diagnosing MI. The normal cardiac enzyme levels in these situations may lead to false negatives, as the test would fail to detect MI due to low or normal enzyme release.

**Why Each Wrong Option is Incorrect:**

**A. Acute coronary syndromes with normal cardiac enzymes:** As explained above, Troponin-T and CPK-MB are less useful in diagnosing MI when cardiac enzymes are normal.

**B. Acute myocardial infarction with elevated CPK-MB:** CPK-MB can be elevated in various conditions beyond MI, leading to false positives. However, Troponin-T remains a more specific marker for MI, making it a better option for diagnosis.

**C. Acute myocardial infarction with low cardiac enzyme release:** Similar to option A, low enzyme release makes Troponin-T and CPK-MB less useful for diagnosing MI.

**D. Acute myocardial infarction with significant renal dysfunction:** Renal dysfunction can lead to elevated CPK-MB levels, making it a less specific marker for MI compared to Troponin-T. However, Troponin-T remains a more specific marker for MI, making it a better option for diagnosis despite renal dysfunction.

**Clinical Pearl:** In clinical practice, Troponin-T is preferred over CPK-MB when diagnosing acute myocardial infarction due to its higher sensitivity and specificity for cardiac injury. However, the choice of biomarker depends on the clinical context and available laboratory resources. In some cases, CPK-MB may be preferred due to its greater sensitivity in detecting myocardial necrosis caused by myocyte necrosis, but Troponin-T is still more specific for cardiac injury.